Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Early Skin Manifestations in a Newly Defined Autoimmune Disease
1
Mins
July 2024
Recent study highlights the early skin manifestations of VEXAS syndrome
Read more
1
Mins
4th May 2018
Recommendation Given for New Psoriasis Treatment
Guselkumab (Tremfya®, Janssen, Beerse, Belgium) has been recommended for the treatment of adults with moderate-to-severe plaque psoriasis by the UK’s…
1
Mins
9th April 2018
Skin Bacteria Can Protect Against Cancer
Skin bacteria could provide protection from several types of cancer, according to the results of a new study carried out at the University of California…
1
Mins
9th April 2018
Approval of Interleukin-23 Antagonist for the Treatment of Plaque Psoriasis
Psoriasis treatment could be revolutionised following the recent approval of an interleukin-23 antagonist, known as tildrakizumab, by the U.S. Food and…
2
Mins
8th March 2018
Charity Finds 30% More Women Living with Undiagnosed Leprosy
Ahead of International Women’s Day, 8th March, UK-based leprosy charity, Lepra has published new research which found 30% more women living with leprosy…
1
Mins
3rd March 2018
Bacterial Strain is Capable of Suppressing Skin Cancer
A strain of bacteria on the skin has the ability to inhibit the growth of skin cancer through the production of a chemical compound, according to…
1
Mins
7th February 2018
Researchers Discover How a Form of Skin Cancer Evades Drug Treatment
NEW targets in the drug development for basal cell carcinoma have been discovered by researchers from Stanford University, California, USA. This…
2
Mins
2nd February 2018
International Specialist Charity Urges UK Government Not to Neglect Leprosy
Colchester, United Kingdom, 31 January, 2018 – Lepra, a UK-based specialist leprosy charity, has warned that failure to include leprosy in a new…
1
Mins
9th January 2018
Skin Fibrosis: Advances in Development and Treatment
DERMAL FIBROBLASTS utilise the highly conserved Wnt/β-catenin pathway to facilitate hair follicle development, wound healing, and structural maintenance…
Loading posts...
« Previous
1
…
8
9
10
11
12
…
16
Next »